Access cutting-edge latent tuberculosis treatment through this clinical trial at a research site in Seattle. Study-provided care at no cost to qualified participants.
Access latent tuberculosis specialists in Seattle at no cost
This study follows strict safety protocols and ethical guidelines
All study-related latent tuberculosis treatment provided free
This study is conducted to compare the safety and effectiveness of a novel short 6-week regimen of daily rifapentine (6wP, experimental arm) with a comparator arm of 12-16 weeks of rifamycin-based treatment (standard of care, control arm) of latent M. tuberculosis infection (LTBI). This trial is conducted among persons who are at increased risk of progression to tuberculosis (TB) and require treatment of LTBI. The study will be conducted in low, medium and high TB incidence settings that have t
Sponsor: Centers for Disease Control and Prevention
Check if you qualify for this latent tuberculosis clinical trial in Seattle, WA
If you're searching for latent tuberculosis treatment options in Seattle, WA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Seattle research site is actively enrolling participants for this clinical trial. You'll receive care from experienced latent tuberculosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.